Post by BioDot, Inc

Building on our legacy. Trailblazing into the future. For more than 30 years, BioDot has helped customers advance precision liquid dispensing across lateral flow, diagnostics, biosensors, microfluidics, and lab-on-a-chip applications. Now, we are entering a new era of discovery. The second edition of The Dot 2026 highlights BioDot’s evolution from a trusted leader in precision dispensing to a partner helping shape the future of science, supporting innovation in genomics, proteomics, drug discovery, miniaturized workflows, and next-generation research. As Brian Kirk, General Manager of BioDot, shares in his opening message, our future is being built with our customers, not just for them. Their feedback, challenges, and real-world applications continue to guide our innovation and improvement. Read the latest edition of The Dot and discover how BioDot is building on 30+ years of innovation while trailblazing into the future of discovery: https://lnkd.in/g4w2Dfcp Many thanks to all our customers and leaders who contributed to the Dot, OPERON, RAPIvD, SSID Group - Disease surveillance & Vaccine development, Hiroki Shigemori, Synevo Romania, Rob Rich, Holly Darban, and BioDot leaders. #BioDot #PrecisionDispensing #DiscoveryScience #LifeSciences #LateralFlow #Diagnostics #Innovation #ATSLifeSciences #genomics, #ATSLSGroup, #liquidhandling